Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Ovarian Cancer

Isabelle Ray-Coquard

伊莎贝尔·雷-科夸尔

MD, PhD

🏢Centre Léon Bérard / Université Claude Bernard Lyon 1(里昂贝拉尔中心/克劳德·伯纳德里昂第一大学)🌐France

Professor of Medical Oncology; Head, Gynecological Oncology Unit肿瘤内科学教授;妇科肿瘤组主任

56
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Isabelle Ray-Coquard, MD, PhD is a Professor of Medical Oncology at Centre Léon Bérard and a leading expert on ovarian cancer biology and treatment. She led the PAOLA-1 trial, which established olaparib plus bevacizumab as first-line maintenance, significantly advancing PARP inhibitor and anti-angiogenic combination strategies in ovarian cancer.

Share:

🧪Research Fields 研究领域

Ovarian Cancer卵巢癌
PARP InhibitorsPARP抑制剂
Bevacizumab贝伐珠单抗
Olaparib Combinations奥拉帕尼联合治疗
BRCA and HRD BiomarkersBRCA与HRD生物标志物

🎓Key Contributions 主要贡献

PAOLA-1 Trial: Olaparib plus Bevacizumab First-Line Maintenance

Led the PAOLA-1/ENGOT-ov25 phase III trial demonstrating that adding olaparib to bevacizumab maintenance prolonged PFS in newly diagnosed advanced ovarian cancer, especially in HRD-positive patients.

HRD Biomarker Strategy in Ovarian Cancer

Championed the incorporation of HRD biomarker testing in clinical trial design and routine practice to stratify patients for PARP inhibitor combinations with bevacizumab.

Representative Works 代表性著作

[1]

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer (PAOLA-1/ENGOT-ov25)

New England Journal of Medicine (2019)

Phase III trial establishing olaparib plus bevacizumab maintenance as a new standard of care for HRD-positive, newly diagnosed advanced ovarian cancer after platinum-taxane chemotherapy.

[2]

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

Annals of Oncology (2023)

Final OS analysis confirming long-term benefit of olaparib-bevacizumab maintenance in HRD-positive patients, with sustained separation of survival curves.

🏆Awards & Recognition 奖项与荣誉

🏆Gustave Roussy Prize for Translational Oncology
🏆ESGO Award for Excellence in Gynecologic Oncology Research
🏆French Society of Medical Oncology Distinguished Investigator Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 伊莎贝尔·雷-科夸尔 的研究动态

Follow Isabelle Ray-Coquard's research updates

留下邮箱,当我们发布与 Isabelle Ray-Coquard(Centre Léon Bérard / Université Claude Bernard Lyon 1)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment